Bill Finger Named Senior Vice President of Global Strategic Services at LabConnect

Bill Finger's New Role at LabConnect

LabConnect, a leader in central laboratory services and scientific consulting, announced the appointment of Bill Finger as Senior Vice President of Global Strategic Services, effective September 10, 2025. Finger arrives with over 25 years of experience in diagnostics and clinical research, having built a notable career in the global laboratory and pharmacy industry.

A Proven Innovator in Healthcare

His leadership in the healthcare space is deeply rooted in a rich history of innovation and strategic execution. Previously, Bill Finger served as Vice President and General Manager of Pharmaceutical Services at Quest Diagnostics, where he demonstrated an exceptional ability to implement strategies that enhance operational performance.

In his former roles, he held various leadership positions, including Executive Vice President of Precision Medicine and Pharma at Cancer Genetics and Director of Operations at Interpace Pharma Solutions. His track record includes significant contributions to scientific affairs and biorepository management at LabCorp, showcasing a breadth of experience well-suited for his new role at LabConnect.

Vision for LabConnect

In his new capacity, Finger will oversee LabConnect's Scientific Services, Consulting Services, Data Management, and the Functional Service Provider (FSP) team. His extensive expertise uniquely positions him to lead these divisions towards innovative solutions that meet the evolving needs of their clients.

Wes Wheeler, CEO of LabConnect, expressed confidence in Finger's capabilities, stating, "Bill’s leadership in diagnostics and clinical research will be a cornerstone for LabConnect. His expertise allows us to proactively respond to client needs, provide innovative solutions, and reinforce our commitment to operational excellence for our clients worldwide."

Strengthening Client Relationships

As LabConnect continues to expand its global footprint, Finger's appointment is expected to strengthen client relationships and deliver high-quality service across a diverse range of laboratories and pharmacy clients. His strategic foresight combined with LabConnect's advanced technology and access to significant and emerging markets is set to help drug development companies streamline their operations.

About LabConnect

LabConnect stands out as a premier provider of Central Laboratory Services, FSP Consulting, and Scientific Services, focusing on complex analytical and logistical studies. LabConnect specializes in immuno-oncology, cell and gene therapies, as well as rare and orphan diseases. The firm’s unique blend of cutting-edge technology, top-notch laboratories, and in-depth expertise in specialized testing provides drug development companies the confidence to rely on a single provider for all their central laboratory service needs.

For more information about LabConnect and its services, visit LabConnect.com and follow on LinkedIn.